Moreover, HSPA5 expression was significantly upregulated in fourteen cancer types, including brain lower-grade glioma (LGG), cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), glioblastoma multiforme (GBM), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), prostate adenocarcinoma (PRAD), stomach adenocarcinoma (STAD), thymoma (THYM), uterine corpus endometrial carcinoma (UCEC), skin cutaneous melanoma (SKCM), and uterine carcinosarcoma (UCS). Here, HSPA5 is linked to cholangiocarcinoma.